Anti-IgE monoclonal antibodies as potential treatment in COVID-19-Reference-Cited by-同舟云学术

Anti-IgE monoclonal antibodies as potential treatment in COVID-19

Published:2021-05-04 Issue:3 Volume:43 Page:259-264
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Farmani Ahmad Reza¹²³^ORCID,Mahdavinezhad Forough⁴,Moslemi Rohollah⁵,Mehrabi Zeinab⁶,Noori Alireza¹,Kouhestani Mahsa¹,Noroozi Zahra⁷,Ai Jafar¹,Rezaei Nima⁸⁹¹⁰^ORCID

Affiliation:

1. Tissue Engineering and Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

2. Tissue Engineering Department, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran

3. Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran

4. Anatomy Department-School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

5. Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

6. Internal Medicine Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

7. Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

8. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

9. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

10. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08923973.2021.1925906

Reference67 articles.

1. COVID-19: Developing from an Outbreak to A Pandemic

2. Coronaviruses pathogenesis, comorbidities and multi-organ damage – A review

3. Coronaviruses and the cardiovascular system: acute and long-term implications

4. Lessons to be learnt from the COVID-19 public health response in Mauritius

5. Public perceptions, anxiety and the perceived efficacy of health-protective behaviours to mitigate the spread of the SARS-Cov-2/ COVID-19 pandemic

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologics for asthma and risk of pneumonia;Journal of Asthma;2024-01-31

2. Early Trends to Show the Efficacy of Cordyceps militaris in Mild to Moderate COVID Inflammation;Cureus;2023-08-18

3. Long-term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?;Dermatology Practical & Conceptual;2023-07-31

4. Omalizumab may protect allergic patients against COVID-19: A systematic review;World Allergy Organization Journal;2023-02

5. Sotrovimab therapy in solid organ transplant recipients with mild to moderate COVID-19: a systematic review and meta-analysis;Immunopharmacology and Immunotoxicology;2022-12-27